This report describes the significance of the kinetic parameters (k-values) obtained from the analysis of dynamic positron emission tomography (PET) scans using the Hawkins model describing the pharmacokinetics of sodium fluoride ([18F]NaF) to understand bone physiology. Dynamic [18F]NaF PET scans may be useful as an imaging biomarker in early phase clinical trials of novel drugs in development by permitting early detection of treatment-response signals that may help avoid late-stage attrition.
Keywords: CT; Hawkins model; PET; [18F] sodium fluoride; [18F]NaF; bone metabolism; clinical significance; computed tomography; dynamic positron emission tomography; kinetic modeling.